A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Treatment Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these accounts privately for source information, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with numerous of members share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Professionals Voice Concerns
Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users administering products of unknown origin.
Some experts stated the popularity for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.
Platform Response and Content Removal
Based on the social media company, the platform has removed violative content and prohibited associated hashtags and query recommendations. The company said it was dedicated to maintaining the service safe and allocating resources in enhancing compliance measures.
Online Marketplace Activities
Research also discovered communities with up to nine thousand participants selling retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, filled with photos of slimming results, positive testimonials and step-by-step guides for mixing or administering at home.
After minutes of joining one group, a vendor shared contact information, where the majority of transactions occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.
Product Information and Costs
Within these groups, posts show dark colored parcels with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how much time a injector should last, vendors give contradictory answers varying between a several days to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for the messaging service said it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting substances they can’t verify. Although the science behind retatrutide is sound, these digital versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has previously encountered patients injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject patients to possibly significant medical dangers”.
